Top Story

Graft-versus-host disease causes enteric bacterial BSI in children after HCT

May 19, 2015

Acute gastrointestinal graft-versus-host disease is likely to cause greater enteric bacterial bloodstream infection density in children who have had allogeneic hematopoietic cell transplantation, according to research published in Clinical Infectious Diseases.

“There remains a paucity of literature documenting that patients with [acute gastrointestinal graft-versus-host disease (aG-GVHD)] are, in fact, at increased risk for enteric bacteremia,” Prakash Satwani, MD, of the Mailman School of Public Health, Columbia University, and colleagues wrote. “The idea that the mucosal barrier injury and disruption of commensal bacteria found in aG-GVHD facilitate bacterial seeding of the bloodstream is still being investigated.”

In the Journals

Gene therapy effectively treats complications of Wiskott-Aldrich syndrome in children

May 18, 2015
In a small cohort of children and adolescents with Wiskott-Aldrich syndrome, autologous hematopoietic stem cell gene therapy led to clinical improvements in symptoms of…
Stephen D. Nimer, MD Industry News

Cancer center director receives award from Bone Marrow Foundation

May 17, 2015
Stephen D. Nimer, MD, director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, received the Dr. E. Donnall Thomas Award…
VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder Meeting News CoverageVideo

VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder

April 27, 2015
Richard J. O’Reilly, MD, chairman of the department of pediatrics at Memorial Sloan Kettering Cancer Center, provides an overview of trials evaluating a large…
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Meeting News Coverage Video
4131355725001 th

CD19-targeted T-cells show potential in B-ALL, allogeneic stem cell transplantation

June 19, 2014
CHICAGO — Eunice Wang, MD, associate professor in the department of medicine at Roswell Park Cancer Institute…
More »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
In the Journals

Graft-versus-host disease causes enteric bacterial BSI in children after HCT

May 19, 2015
Acute gastrointestinal graft-versus-host disease is likely to cause greater enteric bacterial bloodstream infection density in children who have…
MPN Updates

MPN Updates

May 18, 2015 Expires: 5/18/2017
As the standards of care for patients with myeloproliferative neoplasms (MPNs) continue to evolve, physicians must stay informed on current research…
In the Journals

Gene therapy effectively treats complications of Wiskott-Aldrich syndrome in children

May 18, 2015
In a small cohort of children and adolescents with Wiskott-Aldrich syndrome, autologous hematopoietic stem cell gene therapy led to clinical…
Stephen D. Nimer, MD Industry News

Cancer center director receives award from Bone Marrow Foundation

May 17, 2015
Stephen D. Nimer, MD, director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, received the Dr. E…
VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder Meeting News CoverageVideo

VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder

April 27, 2015
Richard J. O’Reilly, MD, chairman of the department of pediatrics at Memorial Sloan Kettering Cancer Center, provides an overview of trials…
Hemant Murthy, MD In PracticePublication Exclusive

State of the science: High-priority transplant trials for nonmalignant disease

HemOnc Today, April 25, 2015
Hemant Murthy, MD; William Wood, MD
Last June, we launched a series of columns in HemOnc Today intended to discuss high-priority proposals that emerged from the 2014 Blood and Marrow…
In the Journals

HSCT associated with increased risk for fractures

April 24, 2015
Patients who underwent hematopoietic stem cell transplantation had a considerably higher incidence of fractures compared with the general population…
Meeting News Coverage

HBV reactivation prevalent after hematopoietic stem cell transplant

April 24, 2015
VIENNA — Hepatitis B virus infection reactivation was prevalent in treatment-naive patients undergoing hematopoietic stem cell transplantation…
Richard J. O’Reilly, MD Meeting News CoveragePerspective

T-cell immunotherapy appears effective in post-HSCT lymphoproliferative disorder

April 20, 2015
PHILADELPHIA — A new type of T cell-based immunotherapy induced response in a majority of patients with Epstein-Barr virus-associated…
In the Journals

Respiratory virus infection before HCT increases mortality

April 17, 2015
Routine testing for respiratory viruses before hematopoietic cell transplantation is reasonable in symptomatic patients and transplantation should…
More Headlines »
morganatic-roan